Under construction – not a live service
Sign in
Taking people in VietnamNo phase

TransAction program to support HIV prevention and care among transgender women

Tests the TransAction counseling and group support program in transgender women.

Plain-language title generated from the registry record
Registry title: Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care

Key facts

Where
Ho Chi Minh City, VietnamSee the site

Where in Vietnam

  • University of Medicine and PharmacyHo Chi Minh City, VietnamTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of California, Los Angeles
Trial code
NCT07495059
Record updated
21 April 2026
Original description
Transgender women in the intervention condition will attend TransAction individual risk reduction sessions; skill building and open group support sessions, and social events between baseline and 3-month assessment. Transgender women participants in the control condition will be invited to social events only.Read full original descriptionShow less

Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care

Transgender women in the intervention condition will attend TransAction individual risk reduction sessions; skill building and open group support sessions, and social events between baseline and 3-month assessment. Transgender women participants in the control condition will be invited to social events only.

Inclusion: 16 years of age or older; being male at birth and currently self-identified as a TW; currently living in Ho Chi Minh City adjacent areas and having no plans to move out of the areas in the next 6 months - have the cognitive capacity to participate in study activities as judged by the study recruiter.

Exclusion: have been involved in intervention adaptation activities previously with the study team; inability to give informed consent/assent.

ClinicalTrials.gov NCT07495059